SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Psychopharmacology
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
0269881106073109v1
21/5/501    most recent
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Web of Science (13)
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Giladi, N.
Right arrow Articles by Peretz, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Giladi, N.
Right arrow Articles by Peretz, C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

New onset heightened interest or drive for gambling, shopping, eating or sexual activity in patients with Parkinson's disease: the role of dopamine agonist treatment and age at motor symptoms onset

Nir Giladi

Movement Disorders Unit and Parkinson Centre, Department of Neurology, Tel-Aviv Sourasky Medical Centre, Tel-Aviv, Israel, nirg{at}tasmc.health.gov.il, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel

Nina Weitzman

Movement Disorders Unit and Parkinson Centre, Department of Neurology, Tel-Aviv Sourasky Medical Centre, Tel-Aviv, Israel

Shaul Schreiber

Department of Psychiatry, Tel-Aviv Sourasky Medical Centre, Tel-Aviv, Israel, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel

Herzel Shabtai

Movement Disorders Unit and Parkinson Centre, Department of Neurology, Tel-Aviv Sourasky Medical Centre, Tel-Aviv, Israel

Chava Peretz

Movement Disorders Unit and Parkinson Centre, Department of Neurology, Tel-Aviv Sourasky Medical Centre, Tel-Aviv, Israel, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

Alterations of impulse control that have recently been associated with Parkinson's disease (PD) are serious behavioural disturbances with significant impact on PD patients and their families.

A total of 193 consecutive PD patients with no history of psychiatric illness and 190 age/gender-matched healthy controls were queried on the presence of new onset heightened interest or drive for gambling, shopping, eating or sexual activity (GSES). Clinical data were retrieved from medical charts and interviews. logistic regressions models assessed risk factors for these specific troublesome behaviours.

New or heightened interests or drives for GSES behaviours were reported by 27 patients (14% vs 0% for controls). Younger age at PD motor symptoms onset (OR = 0.99, p = 0.0172), male gender (OR = 1.10, p = 0.0576) and longer duration of treatment with dopamine agonists (DAs)(OR = 1.18, ≥6 years versus never treated, p = 0.0459) contributed additively to the risk of developing one or more of these behavioural features.

New onset heightened interests or drives for GSES are not rare behavioural disturbances among patients with PD. Age, gender and duration of treatment with DAs have an independent and additive effect on the risk to develop such behavioural changes. Patients should be informed about potential treatment-associated behavioural changes.

Key Words: Parkinson's disease • gambling • hypersexuality • shopping • bulimia • dopamine agonist drugs • impulse control disorder • hedonic homeostatic dysregulation • hypomania • dopamine dysregulation syndrome

This version was published on July 1, 2007

Journal of Psychopharmacology, Vol. 21, No. 5, 501-506 (2007)
DOI: 10.1177/0269881106073109


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement